Mikkel Harndahl
- Immunology top 1%
- Immunotherapy and Immune Responses 20
- T-cell and B-cell Immunology 18
- Immune Cell Function and Interaction 12
- Virology top 2%
- HIV Research and Treatment 6
-
- Monoclonal and Polyclonal Antibodies Research 8
- Molecular Biology top 5%
- vaccines and immunoinformatics approaches 21
- Glycosylation and Glycoproteins Research 3
- Oncology top 10%
-
- Virology and Viral Diseases 3
Mikkel Harndahl
40 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 1.7k
- Virology 288
- Radiology, Nuclear Medicine and Imaging 626
- Molecular Biology 1.7k
- Oncology 439
Countries citing papers authored by Mikkel Harndahl
This map shows the geographic impact of Mikkel Harndahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel Harndahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel Harndahl more than expected).
Fields of papers citing papers by Mikkel Harndahl
This network shows the impact of papers produced by Mikkel Harndahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel Harndahl. The network helps show where Mikkel Harndahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikkel Harndahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 19 | |
| 2 | 2015 | 13 | |
| 3 | 2013 | 16 | |
| 4 | 2013 | 6 | |
| 5 | 2013 | 4 | |
| 6 | 2012 | 7 | |
| 7 | 2012 | 53 | |
| 8 | 2011 | 40 | |
| 9 | 2011 | 12 | |
| 10 | 2011 | 11 | |
| 11 | 2011 | 25 | |
| 12 | 2010 | 25 | |
| 13 | 2009 | 155 | |
| 14 | 2009 | 11 | |
| 15 | 2009 | 46 | |
| 16 | NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11breakdown → | 2008 | 591 |
| 17 | 2008 | 3 | |
| 18 | 2007 | 475 | |
| 19 | 2006 | 92 | |
| 20 | 2006 | 230 |
About Mikkel Harndahl
Mikkel Harndahl is a scholar working on Virology, Immunology and Molecular Biology, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (21 papers), Immunotherapy and Immune Responses (20 papers), T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (12 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), HIV Research and Treatment (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Immunology (1.7k citations), Virology (288 citations) and Radiology, Nuclear Medicine and Imaging (626 citations). Mikkel Harndahl has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Søren Buus, Morten Nielsen, Kasper Lamberth, Ole Lund, Claus Lundegaard, Gustav Røder, Michael Rasmussen, Sune Justesen, Bjoern Peters and Alessandro Sette. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.